# Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

> **NCT02802605** · PHASE3 · UNKNOWN · sponsor: **Instituto de Investigación Marqués de Valdecilla** · enrollment: 225 (estimated)

## Conditions studied

- Cirrhosis and Coagulation

## Interventions

- **DRUG:** Bemiparin

## Key facts

- **NCT ID:** NCT02802605
- **Lead sponsor:** Instituto de Investigación Marqués de Valdecilla
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-06
- **Final completion:** 2019-06
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2016-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02802605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02802605, "Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02802605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*